Physician profile
Mona Kaleem
NPI 1679708424
$7,844.96
in general payments reported to CMS, 2019-2025
11 companies · $1,198 in 2025
The $1,198 reported for 2025 was more than what 81% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $136 · 2020: $189 · 2021: $1,768 · 2022: $3,819 · 2023: $215 · 2024: $521 · 2025: $1,198.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,183 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $750.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,182.73 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $750.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sight Sciences, INC. | $3,508.57 | 2020-2025 | Omni Surgical System, Sion Surgical Instrument |
| Abbvie INC. | $1,717.99 | 2022-2025 | |
| Aerie Pharmaceuticals, INC. | $1,650.25 | 2021 | |
| Allergan, INC. | $223.62 | 2019-2022 | |
| Glaukos Corporation | $177.67 | 2024 | Idose |
| Bausch & Lomb Americas INC. | $133.98 | 2025 | Stellaris, Envista Envy Iol, Vyzulta |
| Tarsus Pharmaceuticals, INC. | $129.39 | 2024 | Xdemvy |
| Dutch Ophthalmic, USA | $104.85 | 2023 | Tissueblue, Eva, Combined Machine |
| Ivantis, INC | $93.97 | 2021 | |
| Alcon Vision LLC | $66.78 | 2023-2025 | Hydrus Microstent, Clareon |
| Regeneron Healthcare Solutions, INC. | $37.89 | 2025 | Eylea Hd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mona Kaleem listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.